According to published reports the frequency of motor neuron disease seems to be fairly uniform throughout most of the world.' 2 Death rates from this disease within and between countries are for the most part between 1 and 1.5 per 100,000 population a year. Motor neuron disease is a disease of late middle life. In developed countries with comparatively elderly populations deaths from motor neuron disease amount to approximately 0 1% of all adult deaths and the average annual incidence rates for motor neuron disease are about 1 to 1*5 per 100,000 population. The duration of the disease after diagnosis is generally 2-5 years,3 and in such countries prevalence rates of 2-6 cases per 100,000 population have been reported.2 However, small areas of increased prevalence, such as Guam (a small island in the Pacific Ocean) and the Kii Peninsula of Japan have been described. In these areas a disease resembling motor neuron disease but accompanied by Parkinsonism and dementia is as much as 100 times more common than reported elsewhere. There is,a&consistent reported male to female excess of 1-5 to 1. In the USA the ratio of cases in whites and blacks is about 1-5: 
Discussion
Morbidity data Before considering the results of these analyses the validity of using first hospital admission for motor neuron disease as a proxy for incidence data must be discussed. Amongst the problems this poses are the incomplete nature of Hospital Activity Analysis, for it is known that several hospitals in both Regions did not contribute to Hospital Activity Analysis until the later part of the study period. Furthermore not all patients with motor neuron disease are admitted to hospital. Although, in our judgement, the majority of recognised cases are admitted at least once for investigation, there will certainly be some cases, particularly those that first occur in extreme old age that, even if they are recognised as motor neuron disease, may not be admitted. There is also the problem that patients may be admitted for the first time at different stages of the disease, from very early to very late in its history. Finally there will certainly be cases, admitted to hospital or not, which are never correctly diagnosed and will therefore not appear in this diagnostic category.
A different problem is the question of movement between regions. The analysis of the Hospital Activity Analysis data are based only on residents in the respective Regions, and exclude patients from out- side coming into the two Regions studied for treatment or diagnosis. This could lead to a systematic loss of data for admissions outside Region of residence. We think that this is unlikely to happen often in the case of residents of the North East Thames Region, which includes the Institute of Neurology, and has working within its boundaries approximately half of the neurologists in the country. Neurological expertise in the Oxford Region is also of a high order and again there is unlikely to be a substantial flow out of the Region for hospital care. For all these reasons however the first admission rate is likely to be an underestimate, rather than an overestimate of the incidence. However the strong similarity between the data for the two regions we have studied suggests that the data are reliable enough for a study of the presenting patterns of the diseases studied. Moreover the data conform closely to what is already known about the diseases from other sources.
Comparing the patterns of motor neuron disease with the patterns of multiple sclerosis and Parkinson's disease (figs 1 and 2), it is very clear that the patterns of the three diseases are different as regards sex ratio and the peak of the age specific rates of first admission. Age-specific rates for motor-neuron disease in both the Oxford and NE Thames Regional Health Authorities indicate a peak at age 70 to 79 and then a fall for females but rise continuously for males up to 80 or more (fig 2) . Parkinson's disease shows a different pattern with a continuing rise with age for both sexes (fig 2) . We are not aware of previous estimates of age-specific incidence rates for motor neuron disease; previous reports only quote frequency distributions. It is therefore worth drawing attention to the fact that incidence rates in males steadily increase with age, although there is a fall in the oldest female age group. The irregular pattern shown for motor neuron-disease suggest the possibility of a small change in risk for different cohorts. 
